The key is that the prior technologies were either

The key is that the prior technologies were either ones that had a reasonably narrow competitive edge over ones that major companies and suppliers had already locked in and were receiving remittances of some sort (kickbacks) or was in a niche that those committed to PCR and other type technologies had a close enough edge that they could ignore the development.

This diagnostic technology is so accurate and comprehensive across a number of critical categories that there is nothing competitive --except when the others cheat and have to be sued for patent infringement. My mantra is that I trust no one. Virtually everyone can be bought when the $$ are enough. So, given the technology as Faro and James Rogers (long term Battelle) describes, there is no equivalent in a critical global emergency. NNLX possesses the tech and has filed for the provisional patent and EUA for it to gain legal protection, there is an incredible need for this specific patented technology in the US, Europe, China (steals), etc. so the reality is that one way or another through a large scale marketing partner or a longer term law suit NNLX "wins". Although experience keeps us from being insane, $.08 or .15, or .50 simply does not make sense. Although we live in an insane nonsensical world. So unless you have a need for $500-$1500 gain you would be nuts to bail. But go ahead.